Pulse Biosciences, Inc.
PLSE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001625101
In the last 90 days, Pulse Biosciences, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $297.0M in total; no superinvestor holds it.
Holders of 5% or more of PLSE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Pulse Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Duggan Robert W | 13D/A | 70.60%48.8M shares | – | Dec 19, 20241 filing | Dec 19, 2024 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Pulse Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 19, 20246:29 AM ET | Duggan Robert Wand 2 others | 13D/A | 70.60%48.8M shares | – | Dec 18, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Pulse Biosciences, Inc. shares.
No Form 144 notices for Pulse Biosciences, Inc. are on file.